Paper of the Month February 2022

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab 

 ​

 

Loading PDF...
100% Open PDF